Whitehawk Therapeutics, Inc. (WHWK)
4.78
+0.01
(+0.21%)
USD |
NASDAQ |
May 27, 16:00
4.78
0.00 (0.00%)
After-Hours: 18:34
Whitehawk Therapeutics Cash from Financing (Quarterly) : 0.00 for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 44.15M |
| Replimune Group, Inc. | 10.45M |
| Lantern Pharma, Inc. | 0.00 |
| Tango Therapeutics, Inc. | 79.85M |
| ACADIA Pharmaceuticals, Inc. | 4.231M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.21M |
| Cash from Investing (Quarterly) | 19.43M |
| Free Cash Flow | -107.78M |
| Free Cash Flow Per Share (Quarterly) | -0.3208 |
| Free Cash Flow to Equity (Quarterly) | -22.21M |
| Free Cash Flow to Firm (Quarterly) | -22.21M |
| Free Cash Flow Yield | -32.59% |